Jaguar Health (JAGX) Return on Sales Growth (3y) (2018 - 2026)

Jaguar Health (JAGX) Return on Sales Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Nanobiotix 1,774.59 Bn 1,774.53 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
3 BeOne Medicines 473.53 Bn 468.74 Bn 1.35 Bn 1.00
4 Vertex Pharmaceuticals 123.91 Bn 116.66 Bn 2.59 Bn 0.00
5 Regeneron Pharmaceuticals 71.79 Bn 63.04 Bn 3.31 Bn 0.00
6 Belite Bio 62.15 Bn 62.15 Bn - -
7 Argenx Se 54.75 Bn 49.57 Bn 1.41 Bn 1.00
8 Alnylam Pharmaceuticals 38.10 Bn 35.10 Bn 959.66 Mn 1.00
9 Revolution Medicines 36.11 Bn 36.11 Bn - -
10 Jaguar Health 509,443.80 -9.55 Mn 19.11 Mn 276.00

Historic Data

Download Data
DateValue
Mar 31, 2026 276.00
Dec 31, 2025 250.00
Sep 30, 2025 1.00
Jun 30, 2025 0.00
Mar 31, 2025 903.00
Dec 31, 2024 4.00
Sep 30, 2024 17.00
Jun 30, 2024 34.00
Mar 31, 2024 6.00
Dec 31, 2023 -1.00
Sep 30, 2023 602.00
Jun 30, 2023 655.00
Mar 31, 2023 -266.00
Dec 31, 2022 -246.00
Sep 30, 2022 4.00
Jun 30, 2022 5.00
Mar 31, 2022 -903.00
Dec 31, 2021 1.00
Sep 30, 2021 -14.00
Jun 30, 2021 -28.00